Published in J Pharm Sci on October 01, 2009
Upregulation of endogenous neurotrophin levels in the brain by intranasal administration of carnosic acid. J Pharm Sci (2011) 0.84
Delivery of brain-derived neurotrophic factor via nose-to-brain pathway. Pharm Res (2011) 0.79
Selective CNS Uptake of the GCP-II Inhibitor 2-PMPA following Intranasal Administration. PLoS One (2015) 0.78
Intranasal, siRNA Delivery to the Brain by TAT/MGF Tagged PEGylated Chitosan Nanoparticles. J Pharm (Cairo) (2013) 0.77
Intranasal Delivery of Recombinant AAV Containing BDNF Fused with HA2TAT: a Potential Promising Therapy Strategy for Major Depressive Disorder. Sci Rep (2016) 0.77
Delivery of ziconotide to cerebrospinal fluid via intranasal pathway for the treatment of chronic pain. J Control Release (2015) 0.76
Enhancement of nose-brain delivery of therapeutic agents for treating neurodegenerative diseases using peppermint oil. Pharmazie (2010) 0.76
Nasal drug delivery--possibilities, problems and solutions. J Control Release (2003) 2.53
Delivery of neurotrophic factors to the central nervous system: pharmacokinetic considerations. Clin Pharmacokinet (2001) 1.96
Clinicopathological findings following intraventricular glial-derived neurotrophic factor treatment in a patient with Parkinson's disease. Ann Neurol (1999) 1.75
Chitosan and its derivatives in mucosal drug and vaccine delivery. Eur J Pharm Sci (2001) 1.46
Delivery of Nerve Growth Factor to the Brain via the Olfactory Pathway. J Alzheimers Dis (1998) 1.39
Effect of chitosan on epithelial cell tight junctions. Pharm Res (2004) 1.34
Chitosan as a novel nasal delivery system for peptide drugs. Pharm Res (1994) 1.30
Effect of chitosan on epithelial permeability and structure. Int J Pharm (1999) 1.27
Transport of molecules from nose to brain: transneuronal anterograde and retrograde labeling in the rat olfactory system by wheat germ agglutinin-horseradish peroxidase applied to the nasal epithelium. Brain Res Bull (1985) 1.13
Brain microdialysis and its application for the study of animal behaviour. Behav Brain Res (1995) 1.11
Distribution of nerve growth factor following direct delivery to brain interstitium. Brain Res (1995) 1.05
Microdialysis measures of functional increases in ACh release in the hippocampus with and without inclusion of acetylcholinesterase inhibitors in the perfusate. J Neurochem (2006) 0.99
Nerve growth factor promotes cholinergic development in brain striatal cultures. Proc Natl Acad Sci U S A (1985) 0.98
Strategies for intranasal delivery of therapeutics for the prevention and treatment of neuroAIDS. J Neuroimmune Pharmacol (2006) 0.97
The olfactory nerve and not the trigeminal nerve is the major site of CNS entry for mouse hepatitis virus, strain JHM. Virology (1993) 0.95
Validation of excised bovine nasal mucosa as in vitro model to study drug transport and metabolic pathways in nasal epithelium. J Pharm Sci (2000) 0.95
Transneuronal transport of peroxidase-conjugated wheat germ agglutinin (WGA-HRP) from the olfactory epithelium to the brain of the adult rat. Exp Brain Res (1986) 0.94
Rapid decrease in transepithelial electrical resistance of human intestinal Caco-2 cell monolayers by cytotoxic membrane perturbents. Toxicol In Vitro (1997) 0.94
Hollow chitosan/poly(acrylic acid) nanospheres as drug carriers. Biomacromolecules (2007) 0.94
Glutathione and thiolated chitosan inhibit multidrug resistance P-glycoprotein activity in excised small intestine. J Control Release (2005) 0.93
Chitosans as nasal absorption enhancers of peptides: comparison between free amine chitosans and soluble salts. Int J Pharm (2000) 0.87
Applications of microdialysis methodology in nonhuman primates: practice and rationale. Crit Rev Neurobiol (2000) 0.84
In vivo monitoring of brain neurotransmitter release for the assessment of neuroendocrine interactions. Cell Mol Neurobiol (1996) 0.82
Distribution of nobiletin chitosan-based microemulsions in brain following i.v. injection in mice. Int J Pharm (2007) 0.81
Intracerebral microdialysis in the study of physiology and behaviour. Rev Neurosci (1994) 0.80
Nerve growth factor (NGF) content in adult rat brain tissues is several-fold higher than generally reported and is largely associated with sedimentable fractions. Brain Res (1996) 0.80
Previously reported nerve growth factor levels are underestimated due to an incomplete release from receptors and interaction with standard curve media. Brain Res (1999) 0.78
Emerging pharmacology of nerve growth factor. Prog Neuropsychopharmacol Biol Psychiatry (1991) 0.77
Recent advances in neonatal pharmacotherapy. Ann Pharmacother (2006) 1.38
Androgen and the elaborate courtship behavior of a tropical lekking bird. Horm Behav (2006) 1.00
Iontophoretic permselective property of human nail. J Dermatol Sci (2007) 0.97
Noninvasive transcutaneous sampling of glucose by electroporation. J Diabetes Sci Technol (2008) 0.95
Limb muscles are androgen targets in an acrobatic tropical bird. Endocrinology (2010) 0.94
Recovery of motor and cognitive function after cerebellar lesions in a songbird: role of estrogens. Eur J Neurosci (2009) 0.91
Trans-ungual iontophoretic delivery of terbinafine. J Pharm Sci (2009) 0.91
Ungual and transungual drug delivery. Drug Dev Ind Pharm (2011) 0.89
Hummingbirds have a greatly enlarged hippocampal formation. Biol Lett (2012) 0.88
Spinal motor and sensory neurons are androgen targets in an acrobatic bird. Endocrinology (2012) 0.87
Behavior, natural history and neuroendocrinology of a tropical bird. Gen Comp Endocrinol (2008) 0.87
Transcutaneous electroporation mediated delivery of doxepin-HPCD complex: a sustained release approach for treatment of postherpetic neuralgia. J Control Release (2009) 0.86
Transcutaneous sampling of ciprofloxacin and 8-methoxypsoralen by electroporation (ETS technique). Int J Pharm (2008) 0.85
Ungual and trans-ungual iontophoretic delivery of terbinafine for the treatment of onychomycosis. J Pharm Sci (2009) 0.85
Androgens regulate gene expression in avian skeletal muscles. PLoS One (2012) 0.84
Upregulation of endogenous neurotrophin levels in the brain by intranasal administration of carnosic acid. J Pharm Sci (2011) 0.84
Transdermal drug delivery enhanced by low voltage electropulsation (LVE). Pharm Dev Technol (2009) 0.83
Alteration of the diffusional barrier property of the nail leads to greater terbinafine drug loading and permeation. Int J Pharm (2009) 0.83
Constant voltage 'Iron'tophoresis. Pharm Dev Technol (2010) 0.82
"ChilDrive": a technique of combining regional cutaneous hypothermia with iontophoresis for the delivery of drugs to synovial fluid. Pharm Res (2009) 0.81
Transungual delivery of terbinafine by iontophoresis in onychomycotic nails. Drug Dev Ind Pharm (2011) 0.80
Iontophoresis across the proximal nail fold to target drugs to the nail matrix. J Pharm Sci (2012) 0.80
Formulation and evaluation of carnosic acid nanoparticulate system for upregulation of neurotrophins in the brain upon intranasal administration. J Drug Target (2012) 0.79
Microporation and 'iron'tophoresis for treating iron deficiency anemia. Pharm Res (2012) 0.79
Electroporation and transcutaneous sampling (ETS) of acyclovir. J Dermatol Sci (2007) 0.79
Iontophoretic drug delivery for the treatment of scars. J Pharm Sci (2014) 0.77
Effect of polyethylene glycols on the trans-ungual delivery of terbinafine. Curr Drug Deliv (2010) 0.77
An ex vivo toe model used to assess applicators for the iontophoretic ungual delivery of terbinafine. Pharm Res (2009) 0.77
Delivery of cefotaxime to the brain via intranasal administration. Drug Dev Ind Pharm (2011) 0.77
Dermal drug levels of antibiotic (cephalexin) determined by electroporation and transcutaneous sampling (ETS) technique. J Pharm Sci (2009) 0.77
Acrobatic courtship display coevolves with brain size in manakins (Pipridae). Brain Behav Evol (2015) 0.77
Enhancement of nose-brain delivery of therapeutic agents for treating neurodegenerative diseases using peppermint oil. Pharmazie (2010) 0.76
Bilayered nail lacquer of terbinafine hydrochloride for treatment of onychomycosis. J Pharm Sci (2010) 0.76
Albumin microspheres for oral delivery of iron. J Drug Target (2010) 0.75
Trans-ungual delivery of itraconazole hydrochloride by iontophoresis. Drug Dev Ind Pharm (2014) 0.75
Controlled-release injectable containing terbinafine/PLGA microspheres for onychomycosis treatment. J Pharm Sci (2014) 0.75
Transdermal iontophoretic delivery of propofol: a general anaesthetic in the form of its phosphate salt. J Pharm Sci (2012) 0.75
In vitro and in vivo evaluation of a hydrogel-based prototype transdermal patch system of alfuzosin hydrochloride. Pharm Dev Technol (2010) 0.75
Brain-derived neurotrophic factor response in vulnerable and resilient genetic lines in the chick anxiety-depression model. Behav Brain Res (2013) 0.75
Iontophoresis for treating nail diseases. Ther Deliv (2013) 0.75
Minimally invasive transdermal delivery of iron-dextran. J Pharm Sci (2012) 0.75
Pretreatment with skin permeability enhancers: importance of duration and composition on the delivery of diclofenac sodium. J Pharm Sci (2014) 0.75